• Phase I clinical study of the...
  • *Holdings*

*Result*: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

*Title*:
Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas / Gunter von Minckwitz, Sebastian Harder, Sascha Hövelmann, Elke Jäger, Salah-Eddin Al-Batran, Sibylle Loibl, Akin Atmaca, Christian Cimpoiasu, Antje Neumann, Aklil Abera, Alexander Knuth, Manfred Kaufmann, Dirk Jäger, Alexander B. Maurer and Winfried S. Wels
*Author/editor-in-chief*:
Minckwitz, Gunter von; Harder, Sebastian; Hövelmann, Sascha ; Jäger, Elke; Batran, Salah-Eddin al- ; Loibl, Sibylle ; Atmaca, Akin ; Cimpoiasu, Christian ; Neumann, Antje; Abera, Aklil; Knuth, Alexander; Kaufmann, Manfred; Jäger, Dirk; Maurer, Alexander B.; Wels, Winfried
*Published in*:
Breast cancer research. - London : BioMed Central, 1999-. - Online-Ressource. - ISSN 1465-542X. - Band 7, Heft 5 (2005)
*show_all_articles*
*Manufacture*:
2005
*Physical description scale*:
Online-Ressource
*Format*:
*eArticle*
*Language*:
*eng*
*DOI*:
10.1186/bcr1264

*Additional information*

*Additional functions*